Michael Ackermann - Director, Tarsus Pharmaceuticals, Inc

As of October 14, 2021


Michael Ackermann Net Worth

  • Net worth is estimated to be at least $32.63M
  • Owns at least 1,215,682 units of Tarsus Pharmaceuticals, Inc stock
  • Sold an estimated value of $446.16K in the last year at Tarsus Pharmaceuticals, Inc

Michael Ackermann Trading

  • Largest sale of shares was 5,633 units , worth over $148K on October 14, 2021
  • In total has made about 8 transactions over a year
  • Usually trades in October and August, with the busiest year in 2021
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Michael Ackermann Mailing Address

  • Mailing address is 202 Carnegie Center Suite 109 Princeton NJ 08540 NJ

Tarsus Pharmaceuticals, Inc Executive Compensation

Name
Year
Salary
Bonus
Option Awards
Other Compensation
Total
Bobak Azamian, M.D. Ph.D. 2020 $437,000 $211,484 $1,847,092 $14,820 $2,510,396
Bobak Azamian, M.D. Ph.D. 2019 $300,000 $116,137 - - $416,137
Leo Greenstein 2020 $256,023 $147,437 $418,703 $13,280 $835,443
Seshadri Neervannan, Ph.D.. 2020 $199,621 $85,248 $1,926,633 $2,175 $2,213,677
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1819790/000119312521144962/d150509ddef14a.htm

Tarsus Pharmaceuticals, Inc Insider Trading

  • The most recent transaction was 5,633 units sold on October 14, 2021 by Michael Ackermann worth over $148K
  • In the last year, insiders at Tarsus Pharmaceuticals, Inc sold an estimated value of $21.97M and bought an estimated value of $14.75M
  • The most active traders are Bobak Azamian, President and CEO,  Michael Ackermann, Director,  and Vivo Capital Fund Ix Lp
  • Insider trading is most common in October, with the busiest year in 2021

Tarsus Pharmaceuticals, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1